Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » BTIG Initiates Coverage of Progenity With Buy Rating

BTIG Initiates Coverage of Progenity With Buy Rating

Oct 23, 2020
|
staff reporter

NEW YORK – BTIG on Friday initiated coverage of Progenity with a Buy rating and a price target of $12 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

What's Popular?

In Business News

  1. Twist Bioscience Proposes $250M Public Offering

  2. Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents

  3. NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022

    Premium

  4. Thermo Fisher Scientific Raises Q4 and 2020 Revenue, Earnings Guidance

  5. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.